Clinical Trial Update: Dose-finding of Multiple Dose of BT061 in Patients With Active Rheumatoid Arthritis Incompletely Controlled on Stable Methotrexate (MTX) [Phase 2]

View source ↗

Summary

Phase 2 dose-finding study evaluating multiple doses of BT061 in active rheumatoid arthritis patients inadequately controlled on methotrexate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• BT061

Snippet

Sponsor: Biotest | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED